Fitness
Detection of Duffy blood group genotypes and submicroscopic Plasmodium infections using molecular diagnostic assays in febrile malaria patients – Malaria Journal
Howard CT, McKakpo US, Qyakyi IA, Bosopem KM, Addison EA, Sun K, et al. Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg. 2007;77:23–6.
Ghebreyesus TA, Haile M, Witten KH, Getachew A, Yohannes M, Lindsay SW, et al. Household risk factors for malaria among children in the Ethiopian highlands. Trans R Soc Trop Med Hyg. 2000;94:17–21.
Peterson I, Borrell LN, El-Sadr W, Teklehaimanot A. Individual and household level factors associated with malaria incidence in a highland region of Ethiopia: a multilevel analysis. Am J Trop Med Hyg. 2009;80:103–11.
Negash K, Kebede A, Medhin A, Argaw D, Babaniyi O, Guintran JO, Delacollette C. Malaria epidemics in the highlands of Ethiopia. East Afr Med J. 2005;82:186–92.
Guthmann JP, Bonnet M, Ahoua L, Dantoine F, Balkan S, van Herp M, Tamrat A, Legros D, Brown V, Checchi F. Death rates from malaria epidemics, Burundi and Ethiopia. Emerg Infect Dis. 2007;13:140–3.
WHO. World malaria report 2017. Geneva: World Health Organization; 2017.
Abraha MW, Nigatu TH. Modeling trends of health and health related indicators in Ethiopia (1995–2008): a time-series study. Health Res Policy Syst. 2009;7:29.
WHO. World Malaria Report 2018. Geneva: World Health Organization; 2018.
Murray CJL. Choosing indicators for the health-related SDG targets. Lancet. 2015;386:1314–7.
Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488–96.
Daniel JW, Bertozzi-Villa A, Susan FR, Punam A, Rohan A, Katherine EB. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2021;21:59–69.
Ray N. Impacts of COVID-19 pandemic on the control of other diseases in Africa: after the waves, the tsunami. Rev Med Suisse. 2021;17:521–3.
Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission: what is the evidence? Trends Parasitol. 2014;30:183–90.
Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267–78.
Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE. 2015;10: e0117229.
Mason SJ, Miller LH, Shiroishi T, Dvorak JA, McGinniss MH. The Duffy blood group determinants: their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. Br J Haematol. 1977;36:327–35.
Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for (Plasmodium knowlesi) malaria: duffy blood group determinants. Science. 1975;189:561–3.
Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype. FyFy N Engl J Med. 1976;295:302–4.
Seixas S, Ferrand N, Rocha J. Microsatellite variation and evolution of the human Duffy blood group polymorphism. Mol Biol Evol. 2002;19:1802–6.
de Carvalho GB, de Carvalho GB. Duffy Blood Group System and the malaria adaptation process in humans. Rev Bras Hematol Hemoter. 2011;33:55–64.
Hodgson JA, Pickrell JK, Pearson LN, Quillen EE, Prista A, Rocha J, Soodyall H, et al. Natural selection for the Duffy-null allele in the recently admixed people of Madagascar. Proc Biol Sci. 2014;281:20140930.
Golassa L, Amenga-Etego L, Lo E, Amambua-Ngwa A. The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health. Malar J. 2020;19:299.
Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455:757–63.
Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, de Sousa B, et al. Duffy negative antigen is no longer a barrier to Plasmodium vivax—molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis. 2011;5: e1192.
Taylor AR, Watson JA, Chu CS, Puaprasert K, Duanguppama J, Day NPJ, et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019;10:5595.
White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.
Voorberg-van DWA, Roma G, Gupta DK, Schuierer S, Nigsch F, Carbone W, et al. A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite Plasmodium cynomolgi. Elife. 2017;6: e29605.
Choi EH, Lee SK, Ihm C, Sohn YH. Rapid DNA extraction from dried blood spots on filter paper: potential applications in biobanking. Osong Public Health Res Perspect. 2014;5:351–7.
Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. 2006: Cambridge University Press.
WHO. Basic Malaria Microscopy. Routine examination of blood films for malaria parasites, Learner’s guide. Geneva: World Health Organization; 2010.
Gillespie SH, Pearson RD. Principles and practice of clinical parasitology. USA: Wiley; 2003.
WHO. Basic Malaria Microscopy, Learner’s guide 2010. Geneva: World Health Organization; 2010.
Gillespie SH, Pearson RD. Principles and practice of clinical parasitology. USA: Wiley Online Library; 2001.
Walsh PS, Metzger DA, Higushi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 2013;10:506–13.
Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–20.
Johnston SP, Pieniazek NJ, Xayavong MV, Slemenda SB, Wilkins PP, da Silva AJ. PCR as a confirmatory technique for laboratory diagnosis of malaria. J Clin Microbiol. 2006;44:1087–9.
Lo E, Yewhalaw D, Zhong D, Zemene E, Degefa T, Tushune K, et al. Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia. Malar J. 2015;14:84.
Chittoria A, Mohanty S, Jaiswal YK, Das A. Natural selection mediated association of the Duffy (FY) gene polymorphisms with Plasmodium vivax malaria in India. PLoS ONE. 2012;7: e45219.
Abagero BR, Kepple D, Pestana K, Witherspoon L, Hordofa A, Adane A, et al. Low density Plasmodium infections and G6PD Deficiency among malaria suspected febrile individuals in Ethiopia. Front Trop Dis. 2022;3: 966930.
Hawash Y, Ismail K, Alsharif K, Alsanie W. Malaria prevalence in a low transmission area, Jazan District of Southwestern Saudi Arabia. Korean J Parasitol. 2019;57:233–42.
Vallejo AF, Chaparro PE, Benavides Y, Álvarez Á, Quintero JP, Padilla J, et al. High prevalence of sub-microscopic infections in Colombia. Malar J. 2015;14:201.
Katrak S, Nayebare P, Rek J, et al. Clinical consequences of submicroscopic malaria parasitaemia in Uganda. Malar J. 2018;17:67.
Kepple D, Pestana K, Tomida J, Abebe A, Golassa L, Lo E. Alternative invasion mechanisms and host immune response to Plasmodium vivax malaria: trends and future directions. Microorganisms. 2020;9:15.
Woldearegai TG, Kremsner PG, Kun JF, Mordmüller B. Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia. Trans R Soc Trop Med Hyg. 2013;107:328–31.
Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, et al. The global distribution of the Duffy blood group. Nat Commun. 2011;2:266.
Mourant AE, Kopeć AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other polymorphisms. Oxford: Oxford University Press; 1976.
Brazeau NF, Whitesell AN, Doctor SM, Keeler C, Mwandagalirwa MK, Tshefu AK, et al. Plasmodium vivax infections in Duffy-negative individuals in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2018;99:1128–33.
Wilairatana P, Masangkay FR, Kotepui KU, Milanez G, Kotepui M. Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis. Sci Rep. 2022;12:3998.
Ngassa MHG, Das A. Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians. PLoS ONE. 2014;9: e103262.
Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA. 2010;107:5967–71.
Lin FC, Li Q, Lin JT. Relapse or reinfection: classification of malaria infection using transition likelihoods. Biometrics. 2020;76:1351–63.
Mikolajczak SA, Vaughan AM, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe. 2015;17:526–35.
Ketzis JK, Fogarty EA, Marttini K, Bowman DD. Explaining premunition with Kin selection using Haemonchus contortus. Parasitology. 2016;143:1187–92.
Flannery EL, Kangwanrangsan N, Chuenchob V, Roobsoong W, Fishbaugher M, Zhou K, et al. Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine. Mol Ther Methods Clin Dev. 2022;26:427–40.